AMCAL and Guardian Pharmacies
are getting behind Kidney Health
Week (22-29 May), with the
initiative urging all Australians to
check their kidney health because
it’s possible to lose 90% of kidney
function without symptoms.
About 1.7 million Australians have
indicators of chronic kidney disease
but under 10% realise they have
the condition.
Amcal, Amcal Max and Guardian
Pharmacies are offering the
KidneyCheck program developed by
Kidney Health Australia.
It has been designed for people
with high blood pressure and
diabetes to quickly and easily
monitor kidney health by checking
their urine for protein.
Members of the Defence Health
private health fund are in some
cases also eligible for a funded
KidneyCheck.The above article was sent to subscribers in Pharmacy Daily's issue from 25 May 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 May 16
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.